SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?

To: B.REVERE who wrote (334)6/16/1998 5:18:00 PM
From: Ibexx  Read Replies (1) | Respond to of 1722
 
Let him short, don't stop him.

I, for one, could use more cheap shares of PFE.

Ibexx



To: B.REVERE who wrote (334)6/16/1998 11:34:00 PM
From: Barron Von Hymen  Read Replies (1) | Respond to of 1722
 
re: shorting PFE is big mistake. I agree. Now that they are selling off their med tech division, their slowest growth areas, watch as profit begin to grow at 19+% year over year, since that med tech division was lagging.



To: B.REVERE who wrote (334)6/17/1998 12:41:00 PM
From: Laurens  Read Replies (1) | Respond to of 1722
 
Gigantic Viagra supplies are
being readied for filling pf orders
from Europe and other overseas continents upon approval bythe authorities. Germany will start
selling sometime in September.Once
overseas sales will start in earnest
the turnover of Viagra will easily
surpass the initial sales
in the US.
It would indeed be a mistake to go short on PFE less than 3 months
before the start of the second boom


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News